Avantor, Inc. (AVTR)

Market Cap	16.56B
Revenue (ttm)	6.97B
Net Income (ttm)	321.10M
Shares Out	679.17M
EPS (ttm)	0.47
PE Ratio	51.87
Forward PE	23.77
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5,696,340
Open	24.68
Previous Close	24.60
Day's Range	24.05 - 24.66
52-Week Range	16.63 - 26.16
Beta	1.37
Analysts	Buy
Price Target	26.63 (+9.23%)
Earnings Date	Apr 26, 2024

About AVTR

Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education an...

• Industry: Specialty Chemicals
• Sector: Materials
• IPO Date: May 17, 2019
• Employees: 7,570
• Stock Exchange: NYSE
• Ticker Symbol: AVTR

Financial Performance

In 2023, Avantor's revenue was $6.97 billion, a decrease of -7.26% compared to the previous year's $7.51 billion. Earnings were $321.10 million, a decrease of -51.52%.

Analyst Forecast

According to 18 analysts, the average rating for AVTR stock is "Buy." The 12-month stock price forecast is $26.63, which is an increase of 9.23% from the latest price.

Price Target

$26.63

(9.23% upside)

Analyst Consensus: Buy